CountriesUSA

Products 131 to 140 of 188

Biotech components: N/A
Business models: B2C
Country of production: USA
Country of distribution: N/A
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 484,400
Funding types: Crowdfunding
Industry: N/A
Market status: No longer on the market
Organization type(s): Private Company
Product categories: N/A
Production process: N/A
Source: NASEM Database
Trading symbol: N/A
Value chain stage: N/A
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA + Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/09/28 14:53 (6 years ago)
Known funding amount: 70,000,000 USD
Funding types: Private Funding
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Plant
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Probiotic
Business models: B2B
Country of production: USA
Country of distribution: North America + Africa + Europe + Asia
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/02 06:17 (6 years ago)
Known funding amount: 8,946 USD
Funding types: Crowdfunding
Industry: Health
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Biotech components: Probiotic
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Public Funding + Private Funding
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Closed Production
Source: NASEM Database
Trading symbol: N/A
Value chain stage: Input
Project Cyborg by Autodesk
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Science
Market status: Under Development
Organization type(s): Public Company
Product categories: Design
Production process: Closed Production
Source: SynBio Database
Trading symbol: ADSK (NASDAQ)
Value chain stage: Platform
Pyrolase Cellulase by BASF + Verenium
Biotech components: Enzyme
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Canada + Mexico
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/02/13 15:37 (5 years ago)
Known funding amount: 2,147,483,647 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Open Release
Source: SynBio Database
Trading symbol: BASF SE (XETRA)
Value chain stage: Finished Product
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Research
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/01 09:18 (6 years ago)
Known funding amount: 70,000,000 USD
Funding types: Private Funding
Industry: Food & Agriculture
Market status: On the market
Organization type(s): Private Company
Product categories: Research
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Platform
Resveratrol by Evolva
Biotech components: Microbe
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Europe
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 86,000,000 CHF
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Food + Personal Care (Topical) + Personal Care (Ingested)
Production process: Closed Production
Source: SynBio Database
Trading symbol: EVE (SWX)
Value chain stage: Input
rHuPH20 by Halozyme
Biotech components: Enzyme
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/01 09:37 (6 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Health
Market status: On the market
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: Closed Production
Source: NASEM Database
Trading symbol: HALO (NASDAQ)
Value chain stage: Input
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA + Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/09/28 14:35 (6 years ago)
Known funding amount: 70,000,000 USD
Funding types: Private Funding
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Plant
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product